3DBio Therapeutics, a biotech company in Queens, said it had for the first time used 3-D printing to make...
Read more
3DBio and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant,...
Read more
3D Bio announced that the FDA has granted Rare Pediatric Disease designation for AuriNovo™, an investigational combination product for...
Read more
3D Bio has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear...
Read more
3D Bio announced the appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to its Board of Directors. Dr....
Read more
We are excited to announce that Kairos Venture Partners II, L.P., our second fund, has made its first investment...
Read more